Financhill
Buy
81

CPRX Quote, Financials, Valuation and Earnings

Last price:
$24.43
Seasonality move :
6.75%
Day range:
$24.04 - $24.59
52-week range:
$19.05 - $26.58
Dividend yield:
0%
P/E ratio:
14.14x
P/S ratio:
5.32x
P/B ratio:
3.24x
Volume:
916.3K
Avg. volume:
1.3M
1-year change:
12.18%
Market cap:
$3B
Revenue:
$491.7M
EPS (TTM):
$1.71

Earnings Data

Next earnings date for CPRX
Feb 25
2026
Most recent earnings per share
$0.42
Missed by $0.12
(Nov 5/2025)
Consensus Estimate
$0.54
(Nov 5/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

CPRX Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
02/25/2026 Q4 $141.5M -- -- $0.46 --
11/05/2025 Q3 $136.8M $148.4M $0.42 $0.54 -$0.12
08/06/2025 Q2 $140.4M $146.6M $0.41 $0.54 -$0.14
05/07/2025 Q1 $131.1M $141.4M $0.45 $0.53 -$0.08
02/26/2025 Q4 $134.2M $141.8M $0.44 $0.55 -$0.10
11/07/2024 Q3 $123.4M $128.7M $0.35 $0.51 -$0.16
08/07/2024 Q2 $111.9M $122.7M $0.33 $0.43 -$0.10
05/08/2024 Q1 $98.8M $98.5M $0.19 $0.30 -$0.11
02/28/2024 Q4 $105.9M $110.6M $0.31 $0.46 -$0.15
11/08/2023 Q3 -- -- -$0.29 $0.45 -$0.74
08/09/2023 Q2 -- -- $0.33 $0.41 -$0.08
05/10/2023 Q1 -- -- $0.26 $0.31 -$0.05
03/15/2023 Q4 -- -- $0.22 $0.20 $0.02
11/09/2022 Q3 -- -- $0.20 $0.19 $0.01
08/09/2022 Q2 -- -- $0.20 $0.17 $0.04
05/10/2022 Q1 -- -- $0.12 $0.14 -$0.02
03/16/2022 Q4 -- -- $0.09 $0.12 -$0.03
11/09/2021 Q3 -- -- $0.10 $0.12 -$0.02
08/09/2021 Q2 -- -- $0.11 $0.10 $0.01
05/10/2021 Q1 -- -- $0.07 $0.09 -$0.02
03/15/2021 Q4 -- -- $0.11 $0.07 $0.04
11/09/2020 Q3 -- -- $0.41 $0.10 $0.31
08/10/2020 Q2 -- -- $0.09 $0.09 -$0.00
05/11/2020 Q1 -- -- $0.10 $0.09 $0.01
03/16/2020 Q4 -- -- $0.07 $0.10 -$0.03
11/12/2019 Q3 -- -- $0.13 $0.12 $0.01
08/07/2019 Q2 -- -- $0.10 $0.02 $0.08
05/13/2019 Q1 -- -- -$0.01 -$0.13 $0.12
03/18/2019 Q4 -- -- -$0.14 -- --
11/07/2018 Q3 -- -- -$0.08 -- --
08/07/2018 Q2 -- -- -$0.06 -- --
05/09/2018 Q1 -- -- -$0.06 -- --
03/14/2018 Q4 -- -- -$0.06 -- --
11/08/2017 Q3 -- -- -$0.05 -- --
08/09/2017 Q2 -- -- -$0.05 -- --
05/10/2017 Q1 -- -- -$0.06 -- --
03/15/2017 Q4 -- -- -$0.05 -- --
11/10/2016 Q3 -- -- -$0.05 -- --
08/09/2016 Q2 -- -- -$0.06 -- --
05/10/2016 Q1 -- -- -$0.07 -- --
03/16/2016 Q4 -- -- -$0.07 -- --

Catalyst Pharmaceuticals, Inc. Earnings Questions

  • How Much did Catalyst Pharmaceuticals, Inc. Generate in Revenue Last Quarter?

    Catalyst Pharmaceuticals, Inc. reported $148.4M worth of top line sales in its most recent quarter.

  • Did Catalyst Pharmaceuticals, Inc. Beat Earnings Last Quarter?

    Catalyst Pharmaceuticals, Inc. announced earnings per share of $0.42 which represents a miss of analyst forecast a $0.54 per share.

  • Is Catalyst Pharmaceuticals, Inc. Profitable?

    Catalyst Pharmaceuticals, Inc. reported $116.4M that represents $0.92 per share over the last quarter.

  • What is the Analyst Consensus for Catalyst Pharmaceuticals, Inc. EPS Next Year?

    Catalyst Pharmaceuticals, Inc.'s earnings are forecast to grow from $1.31 per share to $2.06 per share next year representing an increase of 90.91%.

  • When is Catalyst Pharmaceuticals, Inc.'s Earnings Date?

    Catalyst Pharmaceuticals, Inc.'s next earnings date is February 25, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is DocuSign Stock Undervalued?
Is DocuSign Stock Undervalued?

Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…

Is SentinelOne Stock Undervalued?
Is SentinelOne Stock Undervalued?

Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…

Is Broadcom Stock on Sale?
Is Broadcom Stock on Sale?

Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…

Stock Ideas

Buy
59
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 64x

Buy
53
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 37x

Buy
61
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Buy
85
HUT alert for Dec 24

Hut 8 Corp. [HUT] is up 0.65% over the past day.

Buy
63
GPCR alert for Dec 24

Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.

Sell
32
SMX alert for Dec 24

SMX (Security Matters) Plc [SMX] is down 8.94% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock